DOLUTEGRAVIR for Hepatitis b: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 30 adverse event reports in the FDA FAERS database where DOLUTEGRAVIR was used for Hepatitis b.
Most Reported Side Effects for DOLUTEGRAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 1,036 | 9.6% | 93 | 66 |
| Exposure during pregnancy | 776 | 7.2% | 110 | 95 |
| Virologic failure | 770 | 7.2% | 16 | 61 |
| Pathogen resistance | 586 | 5.4% | 2 | 13 |
| Maternal exposure during pregnancy | 517 | 4.8% | 14 | 41 |
| Viral mutation identified | 510 | 4.7% | 4 | 11 |
| Treatment failure | 453 | 4.2% | 96 | 11 |
| Drug ineffective | 447 | 4.2% | 133 | 55 |
| Off label use | 413 | 3.8% | 116 | 48 |
| Blood hiv rna increased | 410 | 3.8% | 12 | 28 |
| Treatment noncompliance | 409 | 3.8% | 20 | 90 |
| Immune reconstitution inflammatory syndrome | 403 | 3.7% | 58 | 208 |
| Headache | 401 | 3.7% | 102 | 76 |
| Pyrexia | 398 | 3.7% | 122 | 154 |
| Death | 397 | 3.7% | 392 | 29 |
Other Indications for DOLUTEGRAVIR
Hiv infection (7,207)
Product used for unknown indication (2,252)
Antiretroviral therapy (241)
Acquired immunodeficiency syndrome (149)
Prophylaxis against hiv infection (95)
Hiv test positive (77)
Maternal exposure timing unspecified (49)
Antiviral treatment (24)
Acute hiv infection (23)
Hiv test (23)
Other Drugs Used for Hepatitis b
TENOFOVIR DISOPROXIL (2,088)
ENTECAVIR (1,583)
LAMIVUDINE (1,057)
TENOFOVIR ALAFENAMIDE (935)
ADEFOVIR DIPIVOXIL (792)
EMTRICITABINE\TENOFOVIR DISOPROXIL (301)
TENOFOVIR (200)
PEGINTERFERON ALFA-2A (166)
TELBIVUDINE (111)
GLECAPREVIR\PIBRENTASVIR (98)